Vaccinating against RSV, in Norfolk, is a mother's hope to reduce her son's hospitalizations


A mother whose son has been admitted to hospital twice with respiratory syncytial virus (RSV) said she hoped a vaccine trial would reduce admissions.

RSV is a leading cause of the chest infection bronchiolitis and one of the main reasons kids under five end up in hospitals.

Oscar, a three-month-old boy, has been registered for the trial by Charlotte Thurnell of Clippesby, Norfolk.

"Very, very scary," the 28-year-old said of the virus.

Oscar in hospital
The James Paget Hospital, according to Charlotte Thurnell, saved Oscar's life.

Oscar was taken directly into a resuscitation area upon admission to the James Paget Hospital in Gorleston-on-Sea at the end of last year.

She said, "They said he had RSV and bronchiolitis.".

"He was being treated by two consultants and seven nurses, and they were very concerned for him.

His life was essentially saved by the James Paget. ".

Dr John Chapman
There is "an epidemic of RSV bronchiolitis every year," according to Dr. John Chapman.

Dr John Chapman, paediatric consultant who is leading the trial at the hospital, said RSV "swamped" children's wards every year.

Some kids might have a little sniffle, but other kids might have respiratory failure and need to go to intensive care units, he explained.

According to Dr. Chapman, a "newer version of a slightly older vaccine" that had been modified to increase the duration of its effects was being used in the trial.

The idea is to give these to kids at the start of winter so they will be protected all season, he said.

"We know the vaccine is safe, that it's been effective in small numbers [of patients], so it needs to be scaled up.

"This study is examining tens of thousands of infants in the UK and throughout Europe. ".

Three-month-old Oscar is taking part in the trial.

Teams were working to immunize as many kids as they could before the trial's end of March deadline, according to Dr. Chapman.

Hospitals from the UK and western Europe participated in the Harmonie Study, a trial.

Source link

You've successfully subscribed to Webosor
Great! Next, complete checkout to get full access to all premium content.
Welcome back! You've successfully signed in.
Unable to sign you in. Please try again.
Success! Your account is fully activated, you now have access to all content.
Error! Stripe checkout failed.
Success! Your billing info is updated.
Billing info update failed.